Clinical Trial Search

Primary: Percent of Appointments at Which Patient-Reported Outcomes Measurement Information System (PROMIS) Scores Are Documented in the Electronic Medical Record (EMR) Note by…

Primary: Participants With Change in Their Physician-assessed Burden Score — 43; 32; 25 Participants

Primary: Overall Survival — 42.0; 43.5 percentage of participants

Primary: Response Rate — 656 Questionnaires

Primary: Emergency Department Treat/Release [EDTR] Event Occurrence Status at Day 30 — 5.8; 6.9; 5.3; 5.8 percentage of patients with event — p=0.214

Primary: Kansas City Cardiomyopathy Questionnaire-12 Score — 79.4; 79.7 score on a scale

Primary: Quality of Life at 12 Months — 80.97; 84.02 units on a scale

Primary: Patient Engagement (Patient Activation Measure) — 70.2; 67.6; 72.7; 70.3 score on a scale

Primary: Change in the Total Memorial Symptom Assessment Scale Mean Score (TMSAS) From Baseline to On-Treatment — -0.10; -0.1 units on a scale

Primary: Symptoms - Trajectory of Change — 77.2; 76.2 score on a scale — p=0.30

Primary: Patient Satisfaction — 285 Participants

Primary: Patient Reported Outcomes Measurement Information System (PROMIS) Scores. — 43.05; 51.51; 48.64; 50.74 units on a scale — p=<0.05

Primary: Treatment Satisfaction Questionnaire for Medication (TSQM) Version 1.4 - Assessment of Global Satisfaction Subscale Score With Teriflunomide Treatment at Week 48 — 68.17…

Primary: Change From Baseline in PROMIS Composite T-Score at 3-Month Follow-up — 3.48; 2.38 T-score — p=0.165

Primary: Percentage of Participants Who Are Very Satisfied/Satisfied/Somewhat Satisfied With the Overall Study Treatment — 69.6; 40.4 Percentage of participants — p== 0.0065

Primary: Enrollment Number — 25 Number of dyad participants

Primary: Psychometric Cross-Sectional Validation of Patient Reported Outcome (PRO): Patient Global Impression of Severity (PGI-S) Respiratory Scale Score at Baseline — 2.5; 2.4…

Primary: Change From Baseline in Parkinson's Disease Questionnaire-39 Item (PDQ-39) Global Score at Month 6 — -12.81 units on a scale — p=< 0.0001

Primary: Number of Domains Considered Relevant by the Panel of Experts When Assessing Treatment Efficacy in Randomized Cancer Trials for Older Patients With Cancer — 7 geriatric…

Primary: Number of Participants With Penile Prosthesis Overall Subject Satisfaction — 34; 34; 0; 0 Participants

Primary: Number of Patients With PRO-CTCAE Adverse Events With Score ≥ 3 — 8; 5; 5; 1 participants

Primary: PRO Adherence — 50.0; 56.9; 34.9 pct. assigned questionnaires completed

Primary: Change From Baseline in Dermatology Life Quality Index (DLQI) Total Score at Week 12 and 24 — -1.8; -0.5 score on a scale

Primary: Short Form Health Survey-12 (SF-12), Physical Symptoms Subscale — 38.167; 38.601; 37.187; 37.108 units on a scale — p=.0679

Primary: Change From Baseline in Routine Assessment of Patient Index Data 3 (RAPID3) Score at Month 6 — 7.12; 5.95; 5.88; 5.94 units on a scale

Primary: Percentage of Participants Fully-Adherent to Buprenorphine — 6; 3 Participants

Primary: To Determine the Association of the Participants Baseline PPQ (Patient Perception Questionnaire) Responses to Predict Adherence to CPAP Treatment at 90 Days. — .04; .14…

Primary: Rosacea Score on the Visual Analog Scale — 4.50; 4.52; 3.77; 3.06 units on a scale

Primary: Measurement of Symptomatology of Patients on Waitlist Via Patient Health Questionnaire (PHQ-9) — 13.41; 13.48; 13.60; 13.00 score on a scale — p=<0.05

Primary: Change From Baseline in Acne Symptom and Impact Scale Questionnaire (ASIS) Domain Score at Week 12 — 1.96; -0.77; 2.06; -1.01 Score on a Scale — p=<.0001